AstraZeneca withdraws COVID-19 vaccine, citing low demand
Posted on AllSides May 8th, 2024
From The Center
Plyushkin/Pond5 Images/IMAGO
The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision.
"As multiple, variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied," various media outlets quoted the company was quoted as saying.
A document hosted by the EU's European Medicines Agency website confirmed that Vaxzevria was no longer authorized in the region.
In an email to DW, virologist Wolfgang Preiser said "the demand for SARS-CoV-2...
